Oncopeptides CEO Sofia Heigis recently gave a presentation at the Stockholm Corporate Finance Life Science Days.
During the presentation, Sofia shared more about the company and its ongoing efforts, including commercialisation in Europe, partnerships in other parts of the world, and the development of its pipeline, among which the recently announced initiative targeting a new disease, glioblastoma.
Watch the presentation via this link (in Swedish).
In connection with the event, Sofia also sat down with Jesper Hagman from Inderes for an interview, where they discussed, among other things, Oncopeptides’ medicines and market potential, the recently completed share issue, new studies, and the company’s growth strategy.
Watch the interview below or via this link: